Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fluorouracil/salicylic acid - Almirall

Drug Profile

Fluorouracil/salicylic acid - Almirall

Alternative Names: Actikerall; LAS-41005

Latest Information Update: 25 Jan 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Laboratorios Almirall
  • Developer Almirall S.A.
  • Class Anti-inflammatories; Antineoplastics; Pyrimidinones; Salicylates
  • Mechanism of Action Keratinocyte inhibitors; Mitosis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Actinic keratosis

Most Recent Events

  • 25 Jan 2019 Flurouracil/salicyclic acid is not yet available in Slovakia and Luxembourg (Topical)
  • 25 Jan 2019 Chemical structure information added
  • 22 Jan 2019 Launched for Actinic keratosis in Czech Republic (Topical) before January 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top